Etodolac for lowering rheumatoid factor

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3140

Patent

active

047420766

ABSTRACT:
A method is disclosed for lowering rheumatoid factor blood levels by administering an effective amount of etodolac.

REFERENCES:
patent: 4533551 (1985-08-01), Martel
patent: 4670462 (1987-06-01), Hatz et al.
patent: 4677132 (1987-06-01), Hayward
Chem. Abst. 101-222257g (1984).
J. S. Goodwin et al, "Administration of Nonsteroidal Anti-Inflammatory Agents in Patients With Rheumatoid Arthritis", JAMA, vol. 250, No. 16, pp. 2485-2488 (1983).
Forre, O. et al, Non-Steroidal Anti-Inflammatory Drugs in Rheumatoid Arthritis" Inflammation, Supplement to vol. 8, 1984.
Pope, R. M. et al, "Differential Effects of Therapeutic Regiments on Specific Classes of Rheumatoid Factor", Ann. Rheum. Dis. 1986; 45; 183-189.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Etodolac for lowering rheumatoid factor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Etodolac for lowering rheumatoid factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Etodolac for lowering rheumatoid factor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1506537

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.